Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants

The ongoing pandemic of COVID-19, caused by SARS-CoV-2, has severely impacted the global public health and socio-economic stability, calling for effective vaccines and therapeutics. In this study, we continued our efforts to develop more efficient SARS-CoV-2 fusion inhibitors and achieved significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Danwei, Zhu, Yuanmei, Jiao, Tao, Wu, Tong, Xiao, Xia, Qin, Bo, Chong, Huihui, Lei, Xiaobo, Ren, Lili, Cui, Sheng, Wang, Jianwei, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216258/
https://www.ncbi.nlm.nih.gov/pubmed/34057039
http://dx.doi.org/10.1080/22221751.2021.1937329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216258/
https://www.ncbi.nlm.nih.gov/pubmed/34057039
http://dx.doi.org/10.1080/22221751.2021.1937329

Ejemplares similares